Lv11
100 积分 2025-08-20 加入
[Expert consensus on immune checkpoint inhibitors for head and neck squamous cell carcinoma]
1个月前
已完结
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
1个月前
已完结
[Expert consensus on PD-L1 expression testing in head and neck squamous cell carcinoma in China (2024 version)]
1个月前
已完结
[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2025 edition)]
4个月前
已完结
Prognostic Impact of Intra-alveolar Tumor Spread in Pulmonary Adenocarcinoma
4个月前
已完结
[Comprehensive Analysis of the Relationship between m6A Methylation Patterns and Immune Microenvironment in Lung Adenocarcinoma]
4个月前
已完结
皖公网安备34019202002308
